BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May

Day

• 1
• 2
• 3
• 5
• 6
• 7
• 8
• 9
• 10
• 12
• 13
• 14
• 15
• 16
• 17
• 19
• 20
• 21
• 22
• 23
• 24
• 26
• 27
• 28
• 29
• 30

• Press Releases

  Lilly reports first-quarter 2026 financial results, raises full year guidance, and highlights momentum of new medicines

  April 30, 2026

   · 

  21 min read
• Press Releases

  Barinthus Bio Reports First Quarter 2026 Financial Results and Updates on Corporate Developments

  April 30, 2026

   · 

  15 min read
• Press Releases

  Palvella Therapeutics to Host First Quarter 2026 Financial Results and Corporate Update Conference Call on May 7, 2026

  April 30, 2026

   · 

  2 min read
• Press Releases

  Medicenna and Fondazione Melanoma Onlus Announce Presentation on NEOCYT Trial at ASCO 2026

  April 30, 2026

   · 

  6 min read
• Press Releases

  Helus Pharma to Participate at the 29th Annual Milken Institute Global Conference

  April 30, 2026

   · 

  5 min read
• Press Releases

  TG Therapeutics to Host Conference Call on First Quarter 2026 Financial Results and Business Update

  April 30, 2026

   · 

  1 min read
• Press Releases

  SIGA to Host Business Update Call on May 7, 2026, Following Release of First-Quarter 2026 Financial Results

  April 30, 2026

   · 

  1 min read
• Press Releases

  Labcorp Announces 2026 First Quarter Results; Raises Full Year 2026 Guidance

  April 30, 2026

   · 

  20 min read
• Press Releases

  Emergent BioSolutions Receives Approval from Singapore Health Sciences Authority for Expanded Indication of ACAM2000® (Smallpox and Mpox (Vaccinia) Vaccine, Live) to Include Mpox

  April 30, 2026

   · 

  5 min read
• Press Releases

  Aptose Biosciences Announces Update on Anticipated Timing of Closing of the Plan of Arrangement with Hanmi Pharmaceutical

  April 30, 2026

   · 

  5 min read